To help keep our community authentic, we're showing information about accounts on Linktree.
Ophthalmology Times has been a member of Linktree for 3 years and joined in May 2023. The social media accounts linked to from Ophthalmology Times are: • Facebook • Instagram • LinkedIn • Email • Threads • X Besides social media accounts, ophthalmologytimes has populated their site with: • Introducing Nicholas Riina, MS Focused on the Future: Growing Up in Optometry, Advancing Ophthalmology | Eye Care Network - Ophthalmology Times • See what’s happening in teen eye care | Eye Care Network - Ophthalmology Times • Root cause–based dry eye classification and the shift toward precision medicine | Eye Care Network - Ophthalmology Times • Lexitas, Ocusun enroll first patient in pilot study of topical eye drop for age-related cataracts | Eye Care Network - Ophthalmology Times • Bausch + Lomb's BL1107 falls short in phase 2 glaucoma trial, redirects program toward geographic atrophy implant | Eye Care Network - Ophthalmology Times • AAO 2026 - American Academy of Ophthalmology • FDA guidance to help accelerate cell and gene therapies | Ophthalmology Times - Clinical Insights for Eye Specialists • www.ophthalmologytimes.com • TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis | Ophthalmology Times - Clinical Insights for Eye Specialists • Opuviz aflibercept biosimilar launches in Europe for retinal diseases | Ophthalmology Times - Clinical Insights for Eye Specialists • Anti-VEGF Case-Based Roundtable® with Michael Ammar, MD • Geographic Atrophy Case-Based Roundtable® with Priya Vakharia, MD • What ‘I’m Fine’ Really Means: An Open Letter from a Thyroid Eye Disease (TED) Patient | Ophthalmology Times - Clinical Insights for Eye Specialists • Reimagining Dry Eye Management: Targeting Tear Function for Sustained Relief | Viewpoints | Ophthalmology Times - Clinical Insights for Eye Specialists • Register for EyeCon 2025 • EyeCon 2025 Connections Board • Demodex blepharitis: Breaking the Cycle with Advanced Treatments • Advancing Cataract Surgery Outcomes with Next-Generation Intraocular Lenses • Enhancing Precision and Control in Ophthalmic Surgery: Advancing Surgical Techniques With Innovative Viscoelastic Delivery • Retina & Eye Snowmass 2025 | Ophthalmology Conference | Colorado, USA • Explore dry eye co-management insights • Ollin Biosciences announces its official launch • Dr. Klufas - Next-Generation Retinal Disease Treatments: Advancing Care in nAMD and DME • Subscribe to our e-newsletter or print issue! • Ophthalmology Times • FDA approves veligrotug-vvze (Lumvoa) for thyroid eye disease across active and chronic stages | Ophthalmology Times - Clinical Insights for Eye Specialists • Belite Bio concludes phase 3 DRAGON study for Stargardt disease • Novel Drug Delivery Methods and Treatment Approaches for Retinal Diseases • CRU Eye Symposium Wine Personality Quiz • Q&A with John Berdahl, MD, on the global cataract burden and the emerging dementia connection | Ophthalmology Times - Clinical Insights for Eye Specialists • Viridian Therapeutics completes enrollment in REVEAL-1 and REVEAL-2 clinical trials for VRDN-003 • Propelling R&D for Novel Retinal Therapies Through Innovative Clinical Trial Design • Rising Star: Introducing Viha Vig, MBChB | Ophthalmology Times - Clinical Insights for Eye Specialists • Ocugen and Kwangdong complete licensing agreement for OCU400 gene therapy in Korea • Case X Global • Kalaris enrolling phase 1b/2 study of TH103 for nAMD • Geographic Atrophy • Researchers find color vision deficiency may impact choroidal diagnosis • Meeting Information - American Academy of Ophthalmology • Deep learning model for AI: Stopping nascent GA in its tracks • OMIDRIA® (phenylephrine and ketorolac) | Official HCP Website • Patients with dry eye suffer from worse sleep quality • VEVYE® Prescription Treatment for Dry Eye • Report of sexual harassment and bullying released regarding The University of British Columbia Faculty of Medicine • Artificial intelligence for the early detection of ectatic corneal diseases • Vascular compromise resulting from hyaluronic acid dermal fillers: More than skin deep